Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK", you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you. If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Goodwin Procter.

Financing Healthy Living

Related Content

California Air Resources Board Posts Draft Scope 1 and 2 GHG Reporting Template

SEC Chairman Vows to Make IPOs Great Again

M&A Activity Continues to Escalate in the Global Hotel Operator Sector

OCC Issues Guidance and Proposed Rules to Reduce Regulatory Burdens on Depository Institutions

SEC Guidance on Operations During the U.S. Federal Government Shutdown

Goodwin Antitrust & Regulatory Shorts: 10 Insights for Understanding and Managing Risk in Below-Threshold M&A

Treasury Seeks Public Comment on Implementation of the GENIUS Act

SEC Publishes Spring 2025 Regulatory (and Deregulatory) Agenda

Vidi Capital Acquires the group CIL11

Best Law Firms 2026 Names Goodwin ERISA Litigation Law Firm of the Year and Recognizes 50 Practice Areas

Bumble Enters into Agreement to Terminate Tax Receivable Agreement for $186 Million

Luncheon with Goodwin at Money 20/20

MeridianLink Completes its Acquisition by Centerbridge for $2.0 Billion

Goodwin Advises ImCheck Therapeutics on Acquisition by Ipsen for Up to €1 Billion

Goodwin Advises FalconX in Acquiring Leading ETP Provider 21shares

Goodwin Advises Avadel Pharmaceuticals on $2.1 Billion Sale to Alkermes

Technology

Private Equity

Mergers & Acquisitions

Capital Markets